Premium
Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients
Author(s) -
Boemi M.,
Sirolla C.,
Testa R.,
Cenerelli S.,
Fumelli P.,
James R. W.
Publication year - 2004
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.2004.01163.x
Subject(s) - pon1 , medicine , paraoxonase , aryldialkylphosphatase , diabetes mellitus , type 2 diabetes , antioxidant , endocrinology , gastroenterology , oxidative stress , biochemistry , genotype , gene , chemistry
Aims To analyse the association of smoking with paraoxonase (PON1) in Type 2 diabetic patients. Methods Type 2 diabetic patients were recruited independently in two centres (Ancona, Italy and Geneva, Switzerland) and serum PON1 mass and activities were assayed. Current smoking status was established and its association with serum PON1 analysed. Results Type 2 diabetic patients who smoked had significantly lower serum PON1 mass and activity. This was evident in both groups of patients, even though Swiss patients were composed of coronary patients. Multivariate analyses established that smoking was an independent determinant of serum PON1 status. Conclusions Smoking is associated with reduced serum levels of the antioxidant enzyme, PON1, even against an already unfavourable background of diabetes and coronary disease. It suggests that a combination of smoking and diabetes may be particularly deleterious for PON1 and consequently for the anti‐oxidant capacity of high‐density lipoproteins.